Ruxu You

859 total citations
35 papers, 689 citations indexed

About

Ruxu You is a scholar working on Oncology, Surgery and Pharmacology. According to data from OpenAlex, Ruxu You has authored 35 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Surgery and 8 papers in Pharmacology. Recurrent topics in Ruxu You's work include Bone health and osteoporosis research (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Bone health and treatments (5 papers). Ruxu You is often cited by papers focused on Bone health and osteoporosis research (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Bone health and treatments (5 papers). Ruxu You collaborates with scholars based in China, Singapore and Malaysia. Ruxu You's co-authors include Kaiping Wang, Yu Zhang, Jinyu Liu, Li Luo, Hongjing Wang, Jun Wang, Yao Cheng, Qiang Li, Qilin Zhang and Hanxiang Wang and has published in prestigious journals such as Advanced Materials, PLoS ONE and Food Research International.

In The Last Decade

Ruxu You

31 papers receiving 681 citations

Peers

Ruxu You
Jinglin Wang China
Ya Wang China
Qilin Zhang China
Sylvie Mercier France
Eveline Aparecida Isquierdo Fonseca de Queiroz Brazil
K.N. Rao United States
Wenbo Ding China
Fang Cheng China
Nariman K. Badr El-Din Egypt
Jinglin Wang China
Ruxu You
Citations per year, relative to Ruxu You Ruxu You (= 1×) peers Jinglin Wang

Countries citing papers authored by Ruxu You

Since Specialization
Citations

This map shows the geographic impact of Ruxu You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruxu You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruxu You more than expected).

Fields of papers citing papers by Ruxu You

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruxu You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruxu You. The network helps show where Ruxu You may publish in the future.

Co-authorship network of co-authors of Ruxu You

This figure shows the co-authorship network connecting the top 25 collaborators of Ruxu You. A scholar is included among the top collaborators of Ruxu You based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruxu You. Ruxu You is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Zhuoran, Biao Zeng, Irene W. Ng, et al.. (2025). Advances in In Vitro Modeling of Cancer‐Stromal Interactions: From Fundamental Insights to Translational Applications. Advanced Materials. 37(50). e12252–e12252.
2.
Liu, Jinyu, et al.. (2025). Cost-Effectiveness and Price Threshold Analysis of Tafolecimab in Chinese Patients with Elevated LDL Cholesterol Despite Statin Therapy. American Journal of Cardiovascular Drugs. 25(4). 547–561.
3.
4.
Deng, Bin, Shijun Li, Ruxu You, & Zhiwen Fu. (2024). Diabetic adverse events associated with three commonly used statins: a disproportionality analysis based on the FDA adverse event reporting system database. Expert Opinion on Drug Safety. 25(2). 355–362. 1 indexed citations
5.
You, Ruxu, Ya Jin, Feng Li, et al.. (2024). Construction of a high-capacity drug microcarrier using diatom frustules. Colloids and Surfaces B Biointerfaces. 248. 114481–114481. 2 indexed citations
6.
Mei, Chao, et al.. (2024). Factors affecting the medication literacy of older adults and targeted initiatives for improvement: a cross-sectional study in central China. Frontiers in Public Health. 11. 1249022–1249022. 4 indexed citations
7.
Fu, Zhiwen, Jinmei Liu, Cong Zhang, et al.. (2024). Hepatitis-related adverse events associated with immune checkpoint inhibitors in cancer patients: an observational, retrospective, pharmacovigilance study using the FAERS database. Frontiers in Pharmacology. 15. 1383212–1383212. 2 indexed citations
8.
Hu, Huiping, Zhiwen Fu, Jinmei Liu, et al.. (2024). Pulmonary haemorrhage and haemoptysis associated with bevacizumab-related treatment regimens: a retrospective, pharmacovigilance study using the FAERS database. Frontiers in Pharmacology. 15. 1339505–1339505. 3 indexed citations
9.
Liu, Jinyu, et al.. (2023). Cost-effectiveness of empagliflozin for the treatment of heart failure: a systematic review. Frontiers in Pharmacology. 14. 1186579–1186579. 1 indexed citations
10.
Liu, Jinyu, et al.. (2023). Methodology and results of cost-effectiveness of LDL-C lowering with evolocumab in patients with acute myocardial infarction in China. Cost Effectiveness and Resource Allocation. 21(1). 93–93. 2 indexed citations
11.
Li, Mingming, et al.. (2023). Characteristic analysis of adverse reactions of five anti-TNFɑ agents: a descriptive analysis from WHO-VigiAccess. Frontiers in Pharmacology. 14. 1169327–1169327. 15 indexed citations
12.
13.
Wan, Yi, Fang Zeng, Haoyu Tan, et al.. (2022). Cost-effectiveness analyses of denosumab for osteoporosis: a systematic review. Osteoporosis International. 33(5). 979–1015. 18 indexed citations
14.
Liu, Jinyu, et al.. (2022). A systematic review of cost‑effectiveness analyses of sequential treatment for osteoporosis. Osteoporosis International. 34(4). 641–658. 11 indexed citations
15.
Wang, Kaiping, Xiawen Yang, Zhi-Jing Wu, et al.. (2020). Dendrobium officinale Polysaccharide Protected CCl4-Induced Liver Fibrosis Through Intestinal Homeostasis and the LPS-TLR4-NF-κB Signaling Pathway. Frontiers in Pharmacology. 11. 240–240. 61 indexed citations
16.
You, Ruxu & Zijie Liu. (2020). Economic Evaluation of Oral Alendronate Therapy for Osteoporosis in Chinese Postmenopausal Women: The Impact of Medication Compliance and Persistence. Frontiers in Pharmacology. 11. 575893–575893. 4 indexed citations
17.
18.
Liu, Jinyu, Ruxu You, Min Guo, et al.. (2014). Tacrolimus Versus Cyclosporine as Primary Immunosuppressant After Renal Transplantation. American Journal of Therapeutics. 23(3). e810–e824. 32 indexed citations
19.
Liu, Jinyu, et al.. (2012). Polysaccharide Isolated from Angelica sinensis Inhibits Hepcidin Expression in Rats with Iron Deficiency Anemia. Journal of Medicinal Food. 15(10). 923–929. 32 indexed citations
20.
You, Ruxu, Kaiping Wang, Jinyu Liu, et al.. (2011). A comparison study between different molecular weight polysaccharides derived fromLentinus edodesand their antioxidant activitiesin vivo. Pharmaceutical Biology. 49(12). 1298–1305. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinglin Wang Breakdown of academic impact, for papers by Ya Wang Breakdown of academic impact, for papers by Qilin Zhang Breakdown of academic impact, for papers by Sylvie Mercier Breakdown of academic impact, for papers by Eveline Aparecida Isquierdo Fonseca de Queiroz Breakdown of academic impact, for papers by K.N. Rao Breakdown of academic impact, for papers by Wenbo Ding Breakdown of academic impact, for papers by Fang Cheng Breakdown of academic impact, for papers by Nariman K. Badr El-Din
Rankless by CCL
2026